SHANGHAI, May 21 (Reuters) - Eli Lilly ( LLY ) said on Tuesday its tirzepatide drug has received approval from Chinese regulators for use to treat type-2 diabetes. Tirzepatide is the active ingredient in the U.S. firm's diabetes drug Mounjaro and weight-loss drug Zepbound. Eli Lilly ( LLY ) did not say when sales would begin in China and how...

(Reuters) - International Business Machines ( IBM ) on Tuesday said that it will release a family of artificial intelligence models as open-source software, and that it will help Saudi Arabia train an AI system in Arabic. The Armonk, New York-based company has taken a different approach to making money from AI than some of its rivals such as Microsoft...

SHANGHAI, May 21 (Reuters) - Eli Lilly ( LLY ) said on Tuesday its tirzepatide drug has received approval from Chinese regulators for use to treat type 2 diabetes. Tirzepatide is the active ingredient in the U.S. firm's diabetes drug Mounjaro and weight-loss drug Zepbound. (Reporting by Andrew Silver; Editing by Muralikumar Anantharaman) ...

By Mimosa Spencer and Elisa Anzolin PARIS/MILAN (Reuters) - Luxury retailers in European cities outside France are jockeying for business from deep pocketed tourists this summer, betting on a surge in visitors avoiding crowds and street closures in Paris during the Olympic Games. Paris will probably be slow, with cities like London, Milan or Barcelona likely seeing a lift in...